Document is current

Any future updates will be listed below

Correction to: Real-world safety and effectiveness of nivolumab in Japanese patients with unresectable advanced or recurrent gastric/gastroesophageal junction cancer that has progressed after chemotherapy: a postmarketing surveillance study

Crossref DOI link: https://doi.org/10.1007/s10120-021-01262-w

Published Online: 2021-11-09

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark